AQR Capital Management
TRIL

AQR Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

AQR Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,895
Closed -$209K – 2342
2021
Q3 		$209K Buy
+11,895
New +$139K ﹤0.01% 2143

Other funds holding TRIL

Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

AQR Capital Management's TRIL Position: Q4 2021 in Review

AQR Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 11,895 shares — an estimated $209K sold.

AQR Capital Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $209K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • AQR Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • AQR Capital Management sold 11,895 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $209K.
  • AQR Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
  • AQR Capital Management's Trillium Therapeutics Inc. position peaked at $209K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.